SETO

SETO Holdings, Inc. SETO

SETO
SETO Holdings, Inc. NBIO
Nascent Biotech, Inc. INLB
Item 9 Labs Corp. JNHMF
Jack Nathan Medical Corp. USRM
U.S. Stem Cell, Inc. RNUGF
ReNeuron Group plc REFG
Medical Cannabis Payment Solutions, Inc. HADV
Health Advance Inc. PFND
Pathfinder Cell Therapy, Inc. IMMB
Immunotech Laboratories, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SETO NBIO INLB JNHMF USRM RNUGF REFG HADV PFND IMMB
6M 25.58 % -69.23 % 0.00 % -90.00 % 0.00 % 0.00 % 0.00 % -20.00 % 0.00 % 0.00 %
YTD -64.00 % -98.42 % 0.00 % -91.11 % 0.00 % 0.00 % 0.00 % -33.33 % 0.00 % 0.00 %
1Y -25.00 % -99.02 % 0.00 % -97.58 % 0.00 % 0.00 % 0.00 % -50.00 % 0.00 % -0.99 %
3Y -64.24 % -99.65 % -99.95 % -99.11 % -98.00 % -99.52 % -96.67 % -95.00 % 0.00 % -50.00 %
5Y -73.27 % -98.70 % -99.99 % -99.96 % -98.33 % -99.91 % -98.81 % -96.83 % -96.83 % 0.00 %
10Y -89.20 % -99.62 % -99.92 % -99.96 % -99.99 % -99.99 % -99.76 % -99.33 % -98.75 % 0.00 %
From the beginning -97.92 % -98.40 % -100.00 % -99.96 % -100.00 % -100.00 % -99.96 % -73.33 % -99.97 % 0.00 %

Dividend